Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |